Основные публикации коллектива:

1. Gomzikova, M. Therapeutic Application of Mesenchymal Stem Cells Derived Extracellular Vesicles for Immunomodulation / Gomzikova, M., James V., Rizvanov A. // Frontiers in Immunology. – 2019 - Vol.10. doi: 10.3389/fimmu.2019.02663. (Impact Factor 2018 = 4.7). Q1
2. Kletukhina, S. Role of mesenchymal stem cell-derived extracellular vesicles in epithelial-mesenchymal transition / S. Kletukhina, O. Neustroeva, V. James, A. Rizvanov, M. Gomzikova // International Journal of Molecular Sciences. – 2019 - Vol. – 20, Issue 19. – Ar.ID 4813. doi: 10.3390/ijms20194813. (Impact Factor 2018 = 4.183). Q2
3. Rizvanov A. Cytochalasin B-induced membrane vesicles-a new cell-free strategy for regenerative medicine / Rizvanov A., Gomzikova M., Kletukhina S., Neustroeva O., Kurbangaleeva S. // EUROPEAN JOURNAL OF CLINICAL INVESTIGATION – 2019 – V.49(Supp1, S6-L3) - P.: 43-43. (Impact Factor 2017 =2.784). Q1.
4. Neustroeva O.A. Mesenchymal stem cells derived membrane vesicles induced by cytochalasin B demonstrate immunomodulatory properties / O.A. Neustroeva, S.V. Kurbangaleeva, S.K. Kletukhina, A.M. Aimaletdinov, A.A. Rizvanov, M.O. Gomzikova // HUMAN GENE THERAPY - 2019 - P.199-200. DOI: 10.1089/hum.2019.29095.abstracts (Impact Factor 2017 =3.855). Q1.
5. Kurbangaleeva S.V. Cytokine profile and immunophenotype of cytochalasin B induced membrane vesicles / S.V. Kurbangaleeva, O.A. Neustroeva, S.K. Kletukhina, A.A. Rizvanov, M.O. Gomzikova // HUMAN GENE THERAPY - 2019 - P.202-203. DOI: 10.1089/hum.2019.29095.abstracts (Impact Factor 2017 =3.855). Q1.
6. Evaluation of Cytochalasin B-Induced Membrane Vesicles Fusion Specificity with Target Cells / M. Gomzikova, S. Kletukhina, S. Kurbangaleeva, A.Rizvanov // BioMed Research International. – 2018. - Vol.– P.1-6 (Impact Factor 2017 = 2.583). Q3.
7. Cytochalasin B-induced membrane vesicles convey angiogenic activity of parental cells / M.O. Gomzikova, M.N. Zhuravleva, R.R.Miftakhova, S.S.Arkhipova, V.G.Evtugin, S.F.Khaiboullina,A.P.Kiyasov, J.L. Persson, , N.P. Mongan, R.G. Pestell, A.A.Rizvanov//Oncotarget. - 2017. – Vol. 8 (41) - P. 70496-70507. DOI: 10.18632/oncotarget.19723. (Impact Factor 2016 = 5.168). Q1.
8. Divergent immunomodulation capacity of individual Myelin Peptides-components of liposomal Therapeutic against Multiple sclerosis / Ivanova VV, Khaiboullina SF, MO Gomzikova, EV Martynova, AM Ferreira, EE Garanina, DI Sakhapov, YA Lomakin, TI Khaibullin, EV Granatov, FA Khabirov, AA Rizvanov, A Gabibov, A Belogurov // Frontiers in immunology. – 2017 - Vol. 8 (1335) - DOI: 10.3389/fimmu.2017.01335 (Impact Factor 2016 =6.429). Q1.
9. Microfluidic droplet platform for ultrahigh-throughput single-cell screening of biodiversity / SS Terekhov, IV Smirnov, AV Stepanova, TV Bobik, YA Mokrushina, NA Ponomarenko, AA Belogurov, MP Rubtsova, OV Kartseva, MO Gomzikova, AA Moskovtsev, AS Bukatin, MV Dubina, ES Kostryukova, VV Babenko, MT Vakhitova, AI Manolov, MV Malakhova, MA Kornienko, AV Tyakht, AA Vanyushkina,  EN Ilina, P Masson, AG Gabibov, S Altman // Proceedings of the national academy of sciences of the united states of America – 2017. – Vol. 114 (10) - P.2550-2555. DOI: 10.1073/pnas.1621226114. (Impact Factor 2016 = 9.661). Q1.
10. Current Trends in Regenerative Medicine: From Cell to Cell-Free Therapy / M.O. Gomzikova, A.A. Rizvanov // BioNanoScience. – 2017. – Vol. 7 (1). – P. 240-245. DOI 10.1007/s12668-016-0348-0.
11. Investigating the properties of membrane vesicles obtained from human cells HEK293 using cytochalasin B / M.O. Gomzikova, A.A. Rizvanov // Genes and Cells. – 2015. – Vol. 10(3). – P. 27-32. (SCOPUS Cited Publication. In Russian).
12. Membrane microvesicles: biological properties and participation in the pathogenesis of diseases / M.O. Gomzikova, R.F. Gaifullina, I.G. Mustafin, V.M. Chernov, Z.R. Miftahova, A.S. Galyavich, A.A. Rizvanov // Cellular Transplantation and Tissue Engineering. – 2013. – Vol. 8(1). – P. 6-11. (SCOPUS Cited Publication. In Russian).